Company: SLDE
Filing Date: 2025-01-22
Form Type: DRS/A
Source: 0000950123-25-000502
Chunk: 20

Company: Slide Insurance Holdings, Inc.
Filing Date: 2025-01-22
Form: DRS/A
Chunk 20
---
 Office of Insurance Regulation (the “FLOIR”) may 
 directly or indirectly affect our ability to declare and pay or the amount of dividends. See “Dividend Policy.”                                                                                                                          |

| Voting rights | Shares of common stock are entitled to one vote per share. For so long as the Substantial Ownership Requirement is met, the Pre-IPO Significant 
 Stockholders will, among other things, be able to                                                                                               |

11

| designate a majority of the nominees for election to our board of directors, including the nominee for election to serve as Chairman of the board of directors. See “Description of Capital 
 Stock.”                                                                                                                                                                                     |

| Directed share program | At our request, the underwriters have reserved up to  % of the shares of common stock offered by this prospectus for sale, at the initial public offering price, to certain individuals associated with us and our stockholders. Any                
 participants in this program shall be prohibited from selling, pledging or assigning any shares sold to them pursuant to this program for a period of 180 days after the date of this prospectus. The sales will be administered by an affiliate of 
 , an underwriter in this offering. The number of shares of common stock available for sale to the general public will be reduced to the extent these persons purchase such reserved shares of common stock. Any reserved                            
 shares of common stock that are not so purchased will be offered by the underwriters to the general public on the same basis as the other shares of common stock offered by this prospectus. See “Underwriting—Directed Share                       
 Program.”                                                                                                                                                                                                                                           |

| Risk factors | You should read the “Risk Factors” section of this prospectus for a discussion of factors to carefully consider before deciding to invest in shares of our common stock. |

The number of shares of our common stock to be outstanding after this offering excludes:

| • |     | 2,735,000 shares of common stock issuable upon the exercise of options outstanding as of September 30, 2024 
 at a weighted average exercise price of $4.66 per share;                                                    |

| • |     | shares of common stock reserved for future issuance under our 2025 Omnibus Incentive Plan 
 (the “2025 Plan”); and                                                                    |

| • |     | 350,735 shares of common stock reserved for future issuance under our 2021 Equity Compensation Plan (the 
 “Prior Plan”).                                                                                           |

Unless we specifically state otherwise, all information in this prospectus assumes:

| •